1-(4-Chlorobenzyl)-1-(4-methoxyphenyl)hydrazine hydrochloride, 98%, 250mg

4-Fluoro-L-phenylalanine methyl ester hydrochloride, 99.0%, 1g

(S)-TERT-BUTYL 3-(PYRIMIDIN-4-YLOXY)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 250mg

(S)-1-Boc-2-piperidineacetic acid, 95.0%, 5g

(2S)-2-(2-Methoxyphenyl)oxirane, 98%, 25g

2-(Ethylamino)acetic acid hydrochloride, 95%, 5g

IBMX, >99%, 100mg

6-Bromo-5-methoxy-2-methyl-2H-indazole, 97%, 250mg

TEMPO, mínimo 98 %, para síntesis, 25 g, envase de vidrio

N-(3,4-Difluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine (Dacomitinib Impurity), 97%, 50mg

2-(3-Methoxyphenyl)-2-methylpropanoic acid, 97.0%, 10g

[5-(3-Thiophen-2-yl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 1g

C-[1-(4-Chloro-phenyl)-cyclopentyl]-methylamine, 95.0%, 1g